Korea BNC Obtains Chinese Patent for Dexibuprofen Liquid Injection
Predicted impact: Low· Actual: −5.5% vs sector, volume 0.2× normal (5 trading days)
Chinese patent registration for an injectable drug; small, routine and no revenue size given.
256840 · KOSDAQ · ₩256840 · 한국비엔씨
Predicted impact: Low· Actual: −5.5% vs sector, volume 0.2× normal (5 trading days)
Chinese patent registration for an injectable drug; small, routine and no revenue size given.
Also known as: BNC Korea / 한국비엔씨 / 256840 / KRX:256840
Source: KRX statistical information